Cargando…
Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas
SIMPLE SUMMARY: The concept of targeted drug delivery (TDD) represents an innovative and effective treatment approach, which was developed with an attempt to minimize damage toward healthy tissues. Radioimmunotherapy (RIT) with radioimmunoconjugates and TDD with antibody–drug conjugates (ADC) both r...
Autores principales: | Etrych, Tomas, Braunova, Alena, Zogala, David, Lambert, Lukas, Renesova, Nicol, Klener, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833783/ https://www.ncbi.nlm.nih.gov/pubmed/35158894 http://dx.doi.org/10.3390/cancers14030626 |
Ejemplares similares
-
BH3 Mimetics in Hematologic Malignancies
por: Klener, Pavel, et al.
Publicado: (2021) -
Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
por: Lidický, Ondřej, et al.
Publicado: (2015) -
Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy
por: Li, Yanan, et al.
Publicado: (2021) -
Micelle-Forming Block Copolymers Tailored for Inhibition of P-gp-Mediated Multidrug Resistance: Structure to Activity Relationship
por: Braunová, Alena, et al.
Publicado: (2019) -
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas
por: Klanova, Magdalena, et al.
Publicado: (2022)